Page last updated: 2024-10-31

moclobemide and Shock

moclobemide has been researched along with Shock in 1 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research Excerpts

ExcerptRelevanceReference
"Two cases of poisoning with moclobemide are presented."3.69[Poisoning with a reversible and selective monoaminooxidase inhibitor]. ( Bested, KM; Eriksen, ND; Pall, M, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pall, M1
Bested, KM1
Eriksen, ND1

Other Studies

1 other study available for moclobemide and Shock

ArticleYear
[Poisoning with a reversible and selective monoaminooxidase inhibitor].
    Ugeskrift for laeger, 1997, Aug-04, Volume: 159, Issue:32

    Topics: Adult; Antidepressive Agents; Benzamides; Critical Care; Drug Overdose; Female; Humans; Moclobemide;

1997